ABOUT PULMOCLEAR 100MG/600MG TABLET

Pulmoclear 100mg/600mg Tablet is a brand name for the generic medicine(s) Acebrophylline (100mg) + Acetylcysteine (600mg). This combination is primarily used to treat respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma, which are characterized by breathing difficulties due to obstructed airways. Acebrophylline is a bronchodilator and mucolytic agent, while Acetylcysteine is a mucolytic that helps in thinning and loosening mucus in the airways, clearing congestion, and making breathing easier.

Pulmoclear 100mg/600mg Tablet is available in tablet form, providing a convenient oral administration route for patients. This medication is produced in India by Fourrts India Laboratories Pvt Ltd, a reputable pharmaceutical company known for its commitment to quality and innovation in healthcare solutions.

Fourrts India Laboratories Pvt Ltd meets WHO Good Manufacturing Practice (GMP) certification criteria according to CDSCO, ensuring that Pulmoclear 100mg/600mg Tablet is manufactured under stringent quality control standards. Alternatives to Pulmoclear 100mg/600mg Tablet include other brands with the same composition, offering similar therapeutic benefits.

INTRODUCTION OF PULMOCLEAR 100MG/600MG TABLET

Pulmoclear 100mg/600mg Tablet is a comprehensive solution for individuals suffering from respiratory conditions that lead to difficulty in breathing. This medication combines the therapeutic effects of Acebrophylline and Acetylcysteine, two potent agents that work synergistically to alleviate symptoms associated with obstructive airway diseases. Acebrophylline, a derivative of theophylline, acts as a bronchodilator, relaxing the muscles in the airways and increasing airflow to the lungs. It also possesses anti-inflammatory properties, reducing swelling and irritation in the airways.

Acetylcysteine, on the other hand, is a well-known mucolytic agent that breaks down the structure of mucus, making it less viscous and easier to expel from the respiratory tract. This dual-action approach not only helps in clearing mucus but also enhances the overall lung function, providing relief from symptoms such as wheezing, coughing, and shortness of breath. Pulmoclear 100mg/600mg Tablet is particularly beneficial for patients with chronic conditions like COPD and asthma, where mucus build-up and airway constriction are common challenges.

By addressing both the obstruction and inflammation in the airways, Pulmoclear 100mg/600mg Tablet offers a holistic approach to managing respiratory conditions. It is designed to improve the quality of life for patients by reducing the frequency and severity of respiratory episodes, allowing them to engage in daily activities with greater ease. Regular use of this medication, as prescribed by a healthcare professional, can lead to significant improvements in respiratory health and overall well-being.

CONDITIONS TREATED BY PULMOCLEAR 100MG/600MG TABLET

Pulmoclear 100mg/600mg Tablet is primarily used to manage and treat conditions such as chronic obstructive pulmonary disease (COPD) and asthma. These conditions are characterized by obstructed airflow, leading to symptoms like persistent cough, wheezing, and difficulty in breathing. The medication helps in reducing these symptoms by improving airflow and clearing mucus from the airways.

MOLECULE NAME

Acebrophylline (100mg) + Acetylcysteine (600mg)

HOW IT WORKS PULMOCLEAR 100MG/600MG TABLET

Pulmoclear 100mg/600mg Tablet works by combining the effects of Acebrophylline and Acetylcysteine. Acebrophylline acts as a bronchodilator, relaxing the muscles in the airways and reducing inflammation, which helps in easing breathing. Acetylcysteine, a mucolytic agent, breaks down mucus, making it less sticky and easier to expel, thus clearing the airways and improving lung function.

COMMON SIDE EFFECTS OF PULMOCLEAR 100MG/600MG TABLET

Common side effects of Pulmoclear 100mg/600mg Tablet may include nausea, vomiting, stomach discomfort, and diarrhea. Some patients may also experience dizziness or headache. It is important to consult a healthcare provider if these side effects persist or worsen.

HOW TO TAKE PULMOCLEAR 100MG/600MG TABLET

Pulmoclear 100mg/600mg Tablet should be taken as prescribed by a healthcare professional. It is usually taken orally with or without food. It is important to follow the dosage instructions carefully and not to exceed the recommended dose. Swallow the tablet whole with a glass of water, and do not crush or chew it.

PRECAUTIONS OF PULMOCLEAR 100MG/600MG TABLET

Before taking Pulmoclear 100mg/600mg Tablet, inform your doctor about any allergies, medical conditions, or other medications you are taking. This medication should be used with caution in patients with liver or kidney problems. Pregnant or breastfeeding women should consult their healthcare provider before using this medication. Avoid alcohol consumption while taking this medication, as it may increase the risk of side effects.

FOOD & DRUG INTERACTIONS OF PULMOCLEAR 100MG/600MG TABLET

Pulmoclear 100mg/600mg Tablet may interact with other medications, such as antibiotics and other bronchodilators. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Avoid consuming alcohol while on this medication, as it may exacerbate side effects.

ALTERNATIVE BRANDS OF PULMOCLEAR 100MG/600MG TABLET

Alternative brands with the same composition as Pulmoclear 100mg/600mg Tablet include Acebrophylline + Acetylcysteine tablets from other manufacturers. Consult your healthcare provider for suitable alternatives if needed.

FACT MEDICINE OF PULMOCLEAR 100MG/600MG TABLET

Pulmoclear 100mg/600mg Tablet is a combination medication used to manage respiratory conditions like COPD and asthma. It combines Acebrophylline, a bronchodilator, and Acetylcysteine, a mucolytic, to improve breathing and clear mucus. Manufactured by Fourrts India Laboratories Pvt Ltd, it meets WHO GMP standards, ensuring high-quality production. Always consult a healthcare provider for proper usage and potential alternatives.